This explains to some extent why investors might have given the company that valuation of 9 billion. If the company faked demos and portrayed results obtained on non Theranos tech as Theranos tech results, most investors can't be blamed for believing the tech worked and it was only a matter of time before all tests could be performed by the tech. What is baffling to me is unless the data was doctored why didn't any o…
Outside of direct "I physically see this patient", people can forget they work in medicine where their answers can mean life or death decisions.
In that situation people end up not wanting to bite the hand that feeds.
When you have automated stuff that has high throughput with little or no human interaction, you seriously limit the opportunity for humans to raise questions.